Introduction Application of artificial intelligence (AI) tools in the healthcare setting gains importance especially in the domain of disease diagnosis. Numerous studies have tried to explore AI in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

For those born around the time of India’s independence, it will evoke instant memories, but in terms of the guard rails of sociopolitical ethics and the human potential to take a “position,” it has ...

Both Anaconda and The Great Flood serve as reflections of their respective genres, showcasing the absurdity of comedy and the chaos of disaster narratives. Anaconda delights with its humorous take on ...

The new major version with a new JIT compiler, a revised parallelization API, and a maturing type system paves the way for ...

Shanda Group has entered a period of renewed visibility, with a series of incubated ventures coming to light over the past several months. At the center of this momentum is its founder, Tianqiao Chen, ...

The Agentic AI Governance Assurance & Trust Engine (AAGATE) translates the high-level functions of NIST AI RMF into a living, Kubernetes-native architecture.

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

Salt Lake City, Utah, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, today announced that its Board ...